Market Analysis

  • 150k Americans are diagnosed with epilepsy each year, and this number is continuing to increase
  • There are 430k active epilepsy cases in California alone, and 110K in Los Angeles
  • Lifetime costs for patients with epilepsy range from $47,000 - $705,000

Market Strategy

  • Our comprehensive test for patients with epilepsy using our microelectrode array is priced at $10,000
  • This provides significant savings as well as improved patient outcomes

Mean Annual Overall Healthcare Cost in Adult Patients with Stable Versus Uncontrolled Epilepsy

Competition

The NeuroDetect Microelectrode Array is more affordable and simple compared to other competitors. Other similar microelectrode array devices on the market range anywhere from $50,000 to $150,000. The NeuroDetect Microelectrode Array is more affordable and easier to use than our competitors.

Company Device Approximate Cost
Axion Biosystems Maestro Pro (High-throughput MEA and live-cell analysis system) $70,000
3Brain BioCAM X (HD-MEA System) $100,000
MaxWell Biosystems MaxOne Single-Well $100,000